David Hung is PRESIDENT AND CEO of Nuvation Bio Inc.. Currently has a direct ownership of 58.8 Million shares of NUVB, which is worth approximately $119 Million. The most recent transaction as insider was on Apr 07, 2025, when has been sold 300,000 shares (Class A Common Stock) at a price of $1.62 per share, resulting in proceeds of $486,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.8M
0.86% 3M change
0.86% 12M change
Total Value Held $119 Million

David Hung Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 07 2025
BUY
Open market or private purchase
$486,000 $1.62 p/Share
300,000 Added 0.51%
58,781,054 Class A Common Stock
Apr 04 2025
BUY
Open market or private purchase
$332,000 $1.66 p/Share
200,000 Added 0.34%
58,481,054 Class A Common Stock
Mar 02 2021
SELL
Other acquisition or disposition
-
368,408 Reduced 0.63%
58,281,054 Class A Common Stock
Feb 10 2021
BUY
Grant, award, or other acquisition
$586,450,120 $10.0 p/Share
58,645,012 Added 50.0%
58,645,012 Class A Common Stock

Also insider at

NVCR
NovoCure Ltd Healthcare
DH

David Hung

PRESIDENT AND CEO
Malvern, PA

Track Institutional and Insider Activities on NUVB

Follow Nuvation Bio Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVB shares.

Notify only if

Insider Trading

Get notified when an Nuvation Bio Inc. insider buys or sells NUVB shares.

Notify only if

News

Receive news related to Nuvation Bio Inc.

Track Activities on NUVB